Douglas A. Michels Sells 25,000 Shares of OraSure Technologies Inc. (OSUR) Stock
OraSure Technologies Inc. (NASDAQ:OSUR) CEO Douglas A. Michels sold 25,000 shares of the business’s stock in a transaction on Monday, September 26th. The shares were sold at an average price of $8.22, for a total transaction of $205,500.00. Following the sale, the chief executive officer now directly owns 756,898 shares of the company’s stock, valued at $6,221,701.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
OraSure Technologies Inc. (NASDAQ:OSUR) opened at 7.89 on Friday. OraSure Technologies Inc. has a one year low of $4.40 and a one year high of $9.05. The firm has a 50-day moving average of $8.06 and a 200-day moving average of $7.24. The company has a market capitalization of $438.68 million, a P/E ratio of 37.57 and a beta of 1.25.
OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.02. The business earned $31.36 million during the quarter, compared to analysts’ expectations of $31.15 million. OraSure Technologies had a return on equity of 7.60% and a net margin of 10.08%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.03 EPS. On average, analysts anticipate that OraSure Technologies Inc. will post $0.27 earnings per share for the current year.
A number of analysts have recently issued reports on the stock. BTIG Research reissued a “buy” rating on shares of OraSure Technologies in a research note on Wednesday, August 24th. Jefferies Group reissued a “buy” rating and set a $10.00 target price (up from $8.00) on shares of OraSure Technologies in a research note on Wednesday, August 31st. TheStreet raised shares of OraSure Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, August 30th. Mizuho reissued an “outperform” rating and set a $8.00 target price on shares of OraSure Technologies in a research note on Tuesday, July 5th. Finally, Canaccord Genuity upped their price objective on shares of OraSure Technologies from $7.00 to $10.00 and gave the stock a “buy” rating in a research note on Wednesday, August 24th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. OraSure Technologies currently has an average rating of “Buy” and an average target price of $8.58.
Large investors have recently bought and sold shares of the company. Walleye Trading LLC raised its position in OraSure Technologies by 61.9% in the second quarter. Walleye Trading LLC now owns 18,300 shares of the company’s stock valued at $108,000 after buying an additional 7,000 shares during the period. Springbok Capital Management LLC raised its position in OraSure Technologies by 126.7% in the first quarter. Springbok Capital Management LLC now owns 16,300 shares of the company’s stock worth $118,000 after buying an additional 9,110 shares during the last quarter. Janney Montgomery Scott LLC raised its position in OraSure Technologies by 3.2% in the second quarter. Janney Montgomery Scott LLC now owns 18,824 shares of the company’s stock worth $121,000 after buying an additional 579 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new position in OraSure Technologies during the first quarter worth about $127,000. Finally, Shikiar Asset Management Inc. raised its position in OraSure Technologies by 28.6% in the second quarter. Shikiar Asset Management Inc. now owns 22,500 shares of the company’s stock worth $133,000 after buying an additional 5,000 shares during the last quarter. Hedge funds and other institutional investors own 79.65% of the company’s stock.
OraSure Technologies Company Profile
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Receive News & Stock Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related stocks with our FREE daily email newsletter.